Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans

Sponsor
Fred Hutchinson Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT04502524
Collaborator
National Cancer Institute (NCI) (NIH)
49
1
2
11.8
4.2

Study Details

Study Description

Brief Summary

This phase I trial studies how well a new electronic (e)-health smoking cessation program (called Vet Flexiquit) works in promoting smoking cessation in low-income veterans who may or may not be ready to quit smoking. The study will compare the new website smoking cessation program to the current standard care website smoking cessation program offered by the Veterans Administration (VA). Both website interventions will be accompanied by a text messaging program that includes: (1) motivational messages, and (2) reminders to use the assigned program. Both of the website interventions can help smokers quit or cut back on how much they smoke, thus dramatically reducing their chances of developing tobacco-related health conditions.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Smoking Cessation Intervention (New website)
  • Behavioral: Smoking Cessation Intervention (Standard of care website)
  • Behavioral: Health Education
  • Other: Health Promotion and Education
  • Other: Questionnaire Administration
Phase 1

Detailed Description

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants use the new website smoking cessation program, which provides values driven, mindfulness based coping skills and utilizes non-judgmental acceptance of uncomfortable internal states like cravings. Participants also receive text messages consisting of motivational messages and reminders to use the program. At the end of the program, participants receive an email with handouts and available resources provided by the VA for continued support for smoking cessation.

ARM II: Participants use the VA standard of care website, which provides educational materials about cessation treatments, tools to cope with urges and relapse, how to stay motivated, and brief tips on coping with physical and mental health problems. Participants also receive text messages consisting of motivational messages and reminders to use the program. At the end of the program, participants receive an email with a handout of available resources provided by the VA for continued support for smoking cessation.

After study randomization, participants are followed up at 1 and 3 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
49 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Official Title:
A Scalable e-Health Smoking Cessation Intervention for Socioeconomically Disadvantaged Veterans
Actual Study Start Date :
Feb 3, 2021
Actual Primary Completion Date :
Jan 28, 2022
Actual Study Completion Date :
Jan 28, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm I (New website program, handout, text message)

Participants complete the new website smoking cessation program which provides values driven, mindfulness based coping skills and utilizes non-judgmental acceptance of uncomfortable internal states like cravings. Participants will also receive text messages consisting of motivational messages and reminders to use the program. At the end of the program, participants receive an email with all session handouts and available resources provided by the VA for continued support for smoking cessation.

Behavioral: Smoking Cessation Intervention (New website)
Complete the new website smoking cessation program
Other Names:
  • Smoking and Tobacco Use Cessation Interventions
  • Behavioral: Health Education
    Receive information about the cost of smoking, benefits of quitting, ways to prepare for quitting, ways to handle triggers and withdrawal symptoms, and available medications to help with quitting. And will receive additional resources available at the VA handout via email at the end of the study.

    Other: Health Promotion and Education
    Receive motivational and reminder text messages

    Other: Questionnaire Administration
    Ancillary studies

    Active Comparator: Arm II (Standard care VA website, handout, text message)

    Participants use the standard of care website, which provides educational materials about cessation treatments, tools to cope with urges and relapse, how to stay motivated, and brief tips on coping with physical and mental health problems. Participants also receive text messages consisting of motivational messages and reminders to use the program. At the end of the program, participants receive an email with a handout of available resources provided by the VA for continued support for smoking cessation.

    Behavioral: Smoking Cessation Intervention (Standard of care website)
    Complete the standard of care website smoking cessation intervention
    Other Names:
  • standard of care
  • standard therapy
  • best practice
  • Behavioral: Health Education
    Receive information about the cost of smoking, benefits of quitting, ways to prepare for quitting, ways to handle triggers and withdrawal symptoms, and available medications to help with quitting. And will receive additional resources available at the VA handout via email at the end of the study.

    Other: Health Promotion and Education
    Receive motivational and reminder text messages

    Other: Questionnaire Administration
    Ancillary studies

    Outcome Measures

    Primary Outcome Measures

    1. Satisfaction with assigned treatment [At 3 months post-randomization]

      Satisfaction ratings regarding the usefulness of specific components of the website program, user comments and suggestions for improvement, presented descriptively. Treatment satisfaction items are reported on a Likert-type scale, with response choices ranging from "not at all satisfied" to "very satisfied". Will dichotomize values at a threshold of "somewhat satisfied" or higher. Will test for differences between arms using a logistic regression model with adjustment for the stratification variable, baseline readiness to quit (high versus low), as well as adjustment for any baseline variables that differ between study arms and are associated with the outcome (i.e., potential confounders).

    2. Number of server-recorded logins to assigned website [At 3 months]

      Will use negative binomial regression with adjustment for the stratification variable, baseline readiness to quit (high versus low), as well as adjustment for any baseline variables that differ between study arms and are associated with the outcome (i.e., potential confounders) to compare treatment effects on the count outcome number of logins.

    3. Duration of website use [At 3 months]

      Will use negative binomial regression with adjustment for the stratification variable, baseline readiness to quit (high versus low), as well as adjustment for any baseline variables that differ between study arms and are associated with the outcome (i.e., potential confounders) to compare treatment groups on the secondary acceptability outcome of duration of site usage (number of days elapsed from first to last use).

    Secondary Outcome Measures

    1. Number of quit attempts [At 3 months]

      Will use a negative binomial model with adjustment for the stratification variable, baseline readiness to quit (high versus low), as well as adjustment for any baseline variables that differ between study arms and are associated with the outcome (i.e., potential confounders) to compare the count outcome number of quit attempts between arms.

    2. Cotinine-confirmed, self-reported abstinence from smoking [In the 7 days prior to the 3-month follow up]

      Will use a logistic regression model with adjustment for the stratification variable, baseline readiness to quit (high versus low), as well as adjustment for any baseline variables that differ between study arms and are associated with the outcome (i.e., potential confounders) to compare smoking abstinence between arms.

    3. Cotinine-confirmed, self-reported abstinence from smoking [In the 30 days prior to the 3-month follow up]

      Will use a logistic regression model with adjustment for the stratification variable, baseline readiness to quit (high versus low), as well as adjustment for any baseline variables that differ between study arms and are associated with the outcome (i.e., potential confounders) to compare smoking abstinence between arms.

    4. Self-reported abstinence from all nicotine and tobacco products (except nicotine replacement therapy) [In the 7 days prior to the 3-month follow up]

      Will use a logistic regression model with adjustment for the stratification variable, baseline readiness to quit (high versus low), as well as adjustment for any baseline variables that differ between study arms and are associated with the outcome (i.e., potential confounders) to compare smoking abstinence between arms.

    5. Change in readiness to quit [Baseline up to 3-month follow-up]

      Will be assessed by the Contemplation Ladder on a scale from 0 (no thought about quitting) to 10 (taking action to quit). Will calculate change score as follow-up minus baseline score and use a linear regression model with adjustment for the baseline value of the measure of interest and for the stratification variable, baseline readiness to quit (high versus low), as well as adjustment for any baseline variables that differ between study arms and are associated with the outcome (i.e., potential confounders) to compare between study arms.

    6. Change in acceptance of smoking triggers [Baseline up to 3-month follow-up]

      Will be assessed by the Avoidance and Inflexibility Scale on a scale ranging from 0 (never/not at all) to 4 (always/very much/extensively). Will calculate change score as follow-up minus baseline score and use a linear regression model with adjustment for the baseline value of the measure of interest and for the stratification variable, baseline readiness to quit (high versus low), as well as adjustment for any baseline variables that differ between study arms and are associated with the outcome (i.e., potential confounders) to compare between study arms.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Participants must be a US veteran

    • Participants must be low-income, as defined by falling below Veterans Health Administration (VHA) national income threshold for no-cost healthcare

    • Participants must be a current smoker, averaging at least 5 cigarettes/day for the last 30 days

    • Participants must have weekly internet access for the next 3 months

    • Participants must self-report current use of a personal email address to receive the link to their assigned web site

    • Participants must self-report being willing to complete all study activities

    • Participants must be willing to receive study-related text messages

    Exclusion Criteria:
    • Currently taking part in any other smoking cessation treatment such as the nicotine patch, nicotine gum, Zyban, in-person counseling, telephone counseling, using a web-based or app-based cessation program

    • Have recent (past 30 days) substance use disorder, suicidal ideation, or psychiatric hospitalization

    • Previous participation in the treatment development stage of the new smoking cessation website program

    • Prior use of the SmokefreeVET web site

    • Member of the same household as another research participant

    • Woman who is pregnant or breastfeeding, or planning to become pregnant

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Bedford VA Research Corporation, Inc. Bedford Massachusetts United States 01730

    Sponsors and Collaborators

    • Fred Hutchinson Cancer Center
    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Jaimee Heffner, Fred Hutch/University of Washington Cancer Consortium

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Fred Hutchinson Cancer Center
    ClinicalTrials.gov Identifier:
    NCT04502524
    Other Study ID Numbers:
    • RG1007109
    • NCI-2020-05587
    • R21CA236980
    • 10097
    First Posted:
    Aug 6, 2020
    Last Update Posted:
    Aug 2, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Aug 2, 2022